CEBINA joins the global efforts to fight COVID-19

17 Apr'20

The Austrian biotech incubator and accelerator CEBINA GmbH announces the initiation of several collaborative projects that address the global health crisis caused by the pandemic spread of the SARS-CoV-2 virus.

CEBINA GmbH in collaboration with Calyxha Biotechnologies GmbH and Professor Robert Konrat, have identified a number of marketed drugs that have the potential to be effective against COVID-19. These drugs have been identified using an in silico prediction platform which uses aradically new approach, and has been validated in several successful drug discovery projects. The prediction is based on the activation of biological pathways shown to be involved in COVID-19. Combinations of these drugs are expected to be especially effective by interfering with different SARS-CoV-2 infection mechanisms.

Back